A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
Clinical trial NCT05839600 · TERMINATED
Trial details
- NCT number
- NCT05839600
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-07
- Primary completion
- 2025-04-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.